Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CARBIDOPA\LEVODOPA Cause Disease progression? 122 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 122 reports of Disease progression have been filed in association with CARBIDOPA\LEVODOPA. This represents 0.2% of all adverse event reports for CARBIDOPA\LEVODOPA.

122
Reports of Disease progression with CARBIDOPA\LEVODOPA
0.2%
of all CARBIDOPA\LEVODOPA reports
40
Deaths
32
Hospitalizations

How Dangerous Is Disease progression From CARBIDOPA\LEVODOPA?

Of the 122 reports, 40 (32.8%) resulted in death, 32 (26.2%) required hospitalization, and 3 (2.5%) were considered life-threatening.

Is Disease progression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CARBIDOPA\LEVODOPA. However, 122 reports have been filed with the FAERS database.

What Other Side Effects Does CARBIDOPA\LEVODOPA Cause?

Fall (7,132) Death (5,403) Dyskinesia (5,368) Tremor (3,689) General physical health deterioration (3,636) On and off phenomenon (3,509) Hallucination (3,367) Drug ineffective (3,205) Parkinson's disease (3,140) Device dislocation (2,937)

What Other Drugs Cause Disease progression?

RITUXIMAB (7,282) CYCLOPHOSPHAMIDE (7,100) DOXORUBICIN (6,165) VINCRISTINE (5,252) PREDNISONE (5,096) BEVACIZUMAB (4,653) DEXAMETHASONE (4,545) CARBOPLATIN (4,538) CAPECITABINE (3,808) ETOPOSIDE (3,776)

Which CARBIDOPA\LEVODOPA Alternatives Have Lower Disease progression Risk?

CARBIDOPA\LEVODOPA vs CARBIMAZOLE CARBIDOPA\LEVODOPA vs CARBOCYSTEINE CARBIDOPA\LEVODOPA vs CARBOMER CARBIDOPA\LEVODOPA vs CARBON DIOXIDE CARBIDOPA\LEVODOPA vs CARBON MONOXIDE

Related Pages

CARBIDOPA\LEVODOPA Full Profile All Disease progression Reports All Drugs Causing Disease progression CARBIDOPA\LEVODOPA Demographics